COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman
Ning W, Xu W, Cong X, Fan H, Gilkeson G, Wu X, Hughes H, Jiang W. COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman. Journal Of Autoimmunity 2022, 132: 102896. PMID: 36029717, PMCID: PMC9385769, DOI: 10.1016/j.jaut.2022.102896.Peer-Reviewed Original ResearchConceptsType I interferonHealthy womenI interferonAutoantibody productionPre-vaccinationAssociated with COVID-19 disease severityBetamethasone dipropionate ointmentMRNA vaccine BNT162b2Human PBMCs in vitroPBMCs in vitroDose of vaccineImmune response to infectious diseasesCOVID-19 disease severityType I IFNResponse to type I IFNsAutoimmune featuresNeutralizing autoantibodiesVaccine BNT162b2Case reportChronic disease pathogenesisInduce autoantibodiesClinical manifestationsAutoimmune responsePlasma levelsResponse to infectious diseases